Dysregulation of the insulin pathway proteins in L1CAM-neuron-derived exosomes was identified in AD pateints, allowing a prediction of pre-clinical biomarkers (~ 10 years) before the onset of symptoms [77]. Here, L1CAM is linked to Alzheimer disease.